554341 ApS: Financial statements 2022
CVR: 37344281
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
554341 ApS (CVR 37344281) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -125,448 and a net result of DKK 536,348 compared with DKK 2,079,745 the year before. Equity in the 2022 report amounted to DKK 4,720,771. The solvency ratio was 31.2%.
- Gross Profit
- DKK -125,448
- Profit/Loss
- DKK 536,348
- Equity
- DKK 4,720,771
- Total Assets
- DKK 15,126,871
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -125 t. | 536 t. | 4.7 mio. | 0 |
| 2021 | - | -92 t. | 2.1 mio. | 4.2 mio. | 0 |
| 2020 | - | -18 t. | 2.6 mio. | 2.7 mio. | 1 |
| 2019 | - | 0 | -682 | 88 t. | 0 |
| 2018 | - | 50 t. | 39 t. | 89 t. | - |
Official annual report
Keep an eye on 554341 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout 554341 ApS
554341 ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named 416 ApS and Øjenhospitalet Danmark Pharma Aps. The management consists of Anders Marcus Fredrik Poulsen. The board consists of Morten Løw (chair), Jens Frederik Hostrup-Henriksen and Julie Wagner Hostrup-Henriksen. The company is owned by GYNGER OG KARRUSELLER ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 710,371 and a net result of DKK 835,032 compared with DKK 2,062,210 the year before. Equity in the 2025 report amounted to DKK 8,347,729.